Synch has advised Colzyx AB regarding a convertible loan from the European Innovation Council Fund.
Colzyx has received financing from EIC Fund for its business to develop innovative wounds care and antimicrobial products. Colzyx’s invention WOUNDCOM accelerates wound healing and has defined antibacterial effects against all bacteria tested so far, including multidrug resistant bacteria, which will combat multidrug resistance (listed by the WHO as one of the biggest threats to global health).
“Colzyx has used Synch as legal advisor for the negotiation and conclusion of the convertible loan agreement with the EIC Fund. We have found Synch to be professional and knowledgeable in this process. In addition, the atmosphere of cooperation with Synch has been characterized by transparency, openness and a strong commitment to creating the best possible agreement.” – Eskil Söderlind, CEO Colzyx AB
Synch’s team consisted of Jonathan Clauss and Cecilia Thuresson.
Synch offers legal services in four business areas – Advisory Services, Project & Transactional Services, Managed Services and Digital Services.
